Last reviewed · How we verify

NCT03410381: EMMA

Ecological Momentary Mental Assessment

Completed NA Last updated 5 February 2021
What this trial tests

NA trial testing Application EMMA in Person at Risk of Suicide in 97 participants. Completed in 26 June 2020.

Timeline
31 May 2018
Primary endpoint
26 June 2020
26 June 2020

Quick facts

Lead sponsorUniversity Hospital, Montpellier
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment97
Start date31 May 2018
Primary completion26 June 2020
Estimated completion26 June 2020
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Montpellier

Who can join

18 and older, any sex, with Person at Risk of Suicide. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Suicide is a major health problem that causes annually a million death worldwide. Suicide and suicide attempts are preventable. A history of self-injuries or suicidal attempts are known to be the most important risk factor for death by suicide. Suicidal ideation is also strongly correlated with suicide attempts. The development of Smartphones applications offers new possibilities for data collection and transmission. Moreover, the online help function, when a suicidal crisis occurs, is the most effective strategy for prevention of suicidal behavior. Specific technologies have been developed to analyse behaviors and experiences of patients in a natural environment, in real life. That is the goal of Ecological Momentary Assessment. The aim of the study is to develop an algorithm to assess and predict the risk of suicidal event occurrence, in order to detect as soon as possible the signs of suicidal crisis. EMMA will be the first application in French, meeting the recommendations for health applications, developed by experts on suicidal behavior and in collaboration with patients which aims to predict suicidal risk. A subsequent study, conducted on a larger population, should allow to validate the predictive algorithm of EMMA. Long-term goal is to improve the care of patients at risk for suicidal behavior.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

  1. A Digital Companion, the Emma App, for Ecological Momentary Assessment and Prevention of Suicide: Quantitative Case Series Study.
    Morgiève M, Genty C, Azé J, Dubois J, et al · · 2020 · cited 22× · PMID 33034567 · DOI 10.2196/15741
  2. Ethical issues and practical barriers in internet-based suicide prevention research: a review and investigator survey.
    Bailey E, Mühlmann C, Rice S, Nedeljkovic M, et al · · 2020 · cited 22× · PMID 32404098 · DOI 10.1186/s12910-020-00479-1
  3. Acceptability and satisfaction with <i>emma</i>, a smartphone application dedicated to suicide ecological assessment and prevention.
    Morgiève M, Yasri D, Genty C, Dubois J, et al · · 2022 · cited 7× · PMID 36032223 · DOI 10.3389/fpsyt.2022.952865
  4. Predicting suicidal ideation from irregular and incomplete time series of questionnaires in a smartphone-based suicide prevention platform: a pilot study.
    Quellec G, Berrouiguet S, Morgiève M, Dubois J, et al · · 2024 · PMID 39242628 · DOI 10.1038/s41598-024-71760-1

Verify or expand the search:

Other University Hospital, Montpellier trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03410381.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing